Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NEUROCRINE

  • FDA Approval
  • Dec. 14, 2024, 00:17 UTC
  • 29
  • 0 comments

FDA approve CRINECERFONT

Comment Full text

NEUROCRINE

  • FDA Approval
  • Dec. 13, 2024, 22:50 UTC
  • 42
  • 0 comments

FDA approve CRINECERFONT

Comment Full text

GALDERMA LABS LP

  • FDA Approval
  • Dec. 13, 2024, 20:37 UTC
  • 39
  • 0 comments

FDA approve NEMOLIZUMAB-ILTO

Comment Full text

DERMAVANT SCI

  • FDA Approval
  • Dec. 13, 2024, 19:13 UTC
  • 45
  • 0 comments

FDA approve TAPINAROF

Comment Full text

PFIZER

  • FDA Approval
  • Dec. 13, 2024, 19:13 UTC
  • 47
  • 0 comments

FDA approve RIMEGEPANT SULFATE

Comment Full text

ORBION PHARMS

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 41
  • 0 comments

FDA approve ARIPIPRAZOLE

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 30
  • 0 comments

FDA approve DIAZOXIDE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 44
  • 0 comments

FDA approve CYTARABINE

Comment Full text

ALEMBIC

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 41
  • 0 comments

FDA approve ACETAZOLAMIDE

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 39
  • 0 comments

FDA approve GLUCAGON

Comment Full text
  • Previous
  • 181
  • 182
  • 183
  • 184
  • 185
  • Next

Search

News categories

  • Technical Exchange News(9878)
  • Event(407)
  • SEC News(167276)
  • FDA Approval(9337)
  • Company Report(721)
  • Business News(111108)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin